-
1
-
-
84900561041
-
-
Available at Accessed May 30
-
World Drug Report 2011, Cannabis market. Available at: Http://www.unodc.org/documents/data-and-analysis/WDR2011/The-cannabis-market. pdf. Accessed May 30, 2013.
-
(2013)
World Drug Report 2011, Cannabis Market
-
-
-
2
-
-
34548523508
-
History of cannabis and its preparations in saga, science, and sobriquet
-
Russo EB. History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers. 2007;4:1614-1648.
-
(2007)
Chem Biodivers
, vol.4
, pp. 1614-1648
-
-
Russo, E.B.1
-
3
-
-
33947489961
-
Isolation, structure, and partial synthesis of an active constituent of hashish
-
Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc. 1964;86:1646-1647.
-
(1964)
J Am Chem Soc
, vol.86
, pp. 1646-1647
-
-
Gaoni, Y.1
Mechoulam, R.2
-
4
-
-
84900544392
-
-
Solvay Pharmaceut icals Inc Available at Accessed May 9, 2013
-
Solvay Pharmaceut icals Inc. Marinols Prescribing Information, 2006. Available at: Http://www.accessdata.fda.gov/drugsatfda-docs/label/2006/ 018651s025s026lbl.pdf. Accessed May 9, 2013.
-
(2006)
Marinols Prescribing Information
-
-
-
5
-
-
84900535112
-
-
RotECoDDEAodais-iAf. A ssessment of dronabinol and its stereo-isomers Available at Accessed May 30
-
RotECoDDEAodais-iAf. A ssessment of dronabinol and its stereo-isomers. Available at: Http://who.int/medicines/areas/quality-safety/4. 2DronabinolCritReview.pdf. Accessed May 30, 2012.
-
(2012)
-
-
-
6
-
-
0032100491
-
The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol
-
Smith FL, Cichewicz D, Martin ZL, et al. The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol. Pharmacol Biochem Behav. 1998;60:559-566.
-
(1998)
Pharmacol Biochem Behav
, vol.60
, pp. 559-566
-
-
Smith, F.L.1
Cichewicz, D.2
Martin, Z.L.3
-
7
-
-
0032925678
-
Enhancement mu opioid antinociception by oral delta9- tetrahydrocannabinol: Dose-response analysis and receptor identification
-
Cichewicz DL, Martin ZL, Smith FL, et al. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: Dose-response analysis and receptor identification. J Pharmacol Exp Ther. 1999;289:859-867.
-
(1999)
J Pharmacol Exp Ther
, vol.289
, pp. 859-867
-
-
Cichewicz, D.L.1
Martin, Z.L.2
Smith, F.L.3
-
8
-
-
0037373238
-
Antinociceptive synergy between delta (9)-tetrahydrocannabinol and opioids after oral administration
-
Cichewicz DL, Mc Carthy EA. Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration. J Pharmacol Exp Ther. 2003;304:1010-1015.
-
(2003)
J Pharmacol Exp Ther
, vol.304
, pp. 1010-1015
-
-
Cichewicz, D.L.1
McCarthy, E.A.2
-
9
-
-
0346099153
-
Synergistic interactions between cannabinoid and opioid analgesics
-
Cichewicz DL. Synergistic interactions between cannabinoid and opioid analgesics. Life Sci. 2004;74:1317-1324.
-
(2004)
Life Sci
, vol.74
, pp. 1317-1324
-
-
Cichewicz, D.L.1
-
10
-
-
39549091694
-
Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy
-
Narang S, Gibson D, Wasan AD, et al. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J Pain. 2008;9:254-264.
-
(2008)
J Pain
, vol.9
, pp. 254-264
-
-
Narang, S.1
Gibson, D.2
Wasan, A.D.3
-
11
-
-
20444399468
-
Molecular and cellular basis of cannabinoid and opioid interactions
-
Viganò D, Rubino T, Parolaro D. Molecular and cellular basis of cannabinoid and opioid interactions. Pharmacol Biochem Behav. 2005;81:360-368.
-
(2005)
Pharmacol Biochem Behav
, vol.81
, pp. 360-368
-
-
Vigano, D.1
Rubino, T.2
Parolaro, D.3
-
12
-
-
33845344400
-
Endocannabinoid mechanisms of pain modulation
-
Hohmann AG, Suplita RL. Endocannabinoid mechanisms of pain modulation. AAPS J. 2006;8:E693-E708.
-
(2006)
AAPS J
, vol.8
-
-
Hohmann, A.G.1
Suplita, R.L.2
-
13
-
-
0026410805
-
Utility of subjective-effects measurements in assessing abuse liability of drugs in humans
-
Fischman MW, Foltin RW. Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict. 1991;86:1563-1570.
-
(1991)
Br J Addict
, vol.86
, pp. 1563-1570
-
-
Fischman, M.W.1
Foltin, R.W.2
-
14
-
-
21744446711
-
Transdermal nicotine alters some of marihuana's effects in male and female volunteers
-
Penetar DM, Kouri EM, Gross MM, et al. Transdermal nicotine alters some of marihuana's effects in male and female volunteers. Drug Alcohol Depend. 2005;79:211-223.
-
(2005)
Drug Alcohol Depend
, vol.79
, pp. 211-223
-
-
Penetar, D.M.1
Kouri, E.M.2
Gross, M.M.3
-
15
-
-
26444598586
-
Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure
-
Hart CL, Haney M, Vosburg SK, et al. Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure. Psychopharmacology (Berl). 2005;181: 237-243.
-
(2005)
Psychopharmacology (Berl
, vol.181
, pp. 237-243
-
-
Hart, C.L.1
Haney, M.2
Vosburg, S.K.3
-
16
-
-
0032006542
-
Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol
-
Kirk JM, Doty P, De Wit H. Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol. Pharmacol Biochem Behav. 1998;59:287-293.
-
(1998)
Pharmacol Biochem Behav
, vol.59
, pp. 287-293
-
-
Kirk, J.M.1
Doty, P.2
De Wit, H.3
-
17
-
-
0026579386
-
Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans
-
Chait LD,Zacny JP, Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans, Psychopharmacology (Berl,1992,107, 255-262.
-
(1992)
Psychopharmacology (Berl
, vol.107
, pp. 255-262
-
-
Chait, L.D.1
Zacny, J.P.2
-
18
-
-
0035987114
-
Comparison o f the subjective effects of Delta (9)-tetrahydrocannabinol and marijuana in humans
-
Wachtel SR, ElSohly MA, Ross SA, et al. Comparison o f the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl). 2002; 161:331-339.
-
(2002)
Psychopharmacology (Berl)
, vol.161
, pp. 331-339
-
-
Wachtel, S.R.1
Elsohly, M.A.2
Ross, S.A.3
-
19
-
-
0036453750
-
Comparison of smoked marijuana and oral delta (9)-tetrahydrocannabinol in humans
-
Hart CL, Ward AS, Haney M, et al. Comparison of smoked marijuana and oral delta(9)-tetrahydrocannabinol in humans. Psychopharmacology (Berl). 2002;164:407-415.
-
(2002)
Psychopharmacology (Berl
, vol.164
, pp. 407-415
-
-
Hart, C.L.1
Ward, A.S.2
Haney, M.3
-
21
-
-
76249132039
-
The abuse potential of the synthetic cannabinoid nabilone
-
Ware MA St, Arnaud-Trempe E. The abuse potential of the synthetic cannabinoid nabilone. Addiction. 2010;105: 494-503.
-
(2010)
Addiction
, vol.105
, pp. 494-503
-
-
Ware, M.A.S.T.1
Arnaud-Trempe, E.2
-
22
-
-
80051985532
-
Abuse potential and psychoactive effects of d-9- tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine
-
Robson P. Abuse potential and psychoactive effects of d-9- tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine. Expert Opin Drug Saf. 2011;10:675-685.
-
(2011)
Expert Opin Drug Saf
, vol.10
, pp. 675-685
-
-
Robson, P.1
-
23
-
-
84900531499
-
-
SAMHSA Fact sheet: National Household survey on Drug Abuse, 2011 Available at
-
SAMHSA Fact sheet: National Household survey on Drug Abuse, 2011. Available at: Http://www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.htm#5.3. Accessed June 6, 2013.
-
(2013)
Accessed June 6
-
-
-
24
-
-
0026643378
-
Drug abuse, dependence, and addiction in chronic pain patients
-
Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8:77-85.
-
(1992)
Clin J Pain
, vol.8
, pp. 77-85
-
-
Fishbain, D.A.1
Rosomoff, H.L.2
Rosomoff, R.S.3
-
25
-
-
0018777651
-
Drug abuse and dependency in patients with chronic pain
-
Maruta T, Swanson DW, Finlayson RE. Drug abuse and dependency in patients with chronic pain. Mayo Clin Proc. 1979;54:241-244.
-
(1979)
Mayo Clin Proc
, vol.54
, pp. 241-244
-
-
Maruta, T.1
Swanson, D.W.2
Finlayson, R.E.3
-
26
-
-
0020037077
-
Self-reported vs. Actual use of medications in chronic pain patients
-
Ready LB, Sarkis E, Turner JA. Self-reported vs. actual use of medications in chronic pain patients. Pain. 1982;12:285-294.
-
(1982)
Pain
, vol.12
, pp. 285-294
-
-
Ready, L.B.1
Sarkis, E.2
Turner, J.A.3
-
27
-
-
5644303369
-
Validation of a screener and opioid assessment measure for patients with chronic pain
-
Butler SF, Budman SH, Fernandez K, et al. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112:65-75.
-
(2004)
Pain
, vol.112
, pp. 65-75
-
-
Butler, S.F.1
Budman, S.H.2
Fernandez, K.3
-
28
-
-
34247523880
-
Development and validation of the Current Opioid Misuse Measure
-
Bu tler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain. 2007;130:144-156.
-
(2007)
Pain
, vol.130
, pp. 144-156
-
-
Butler, S.F.1
Budman, S.H.2
Fernandez, K.C.3
-
29
-
-
0016425051
-
Analgesic effect of delta-9-tetrahydrocannabinol
-
Noyes R, Brunk SF, Baram DA, et al. Analgesic effect of delta-9-tetrahydrocannabinol. J Clin Pharmacol. 1975;15: 139-143.
-
(1975)
J Clin Pharmacol
, vol.15
, pp. 139-143
-
-
Noyes, R.1
Brunk, S.F.2
Baram, D.A.3
-
30
-
-
0028261433
-
Interactions between delta 9- tetrahydrocannabinol and kappa opioids in mice
-
Smith PB, Welch SP, Martin BR. Interactions between delta 9- tetrahydrocannabinol and kappa opioids in mice. J Pharmacol Exp Ther. 1994;268:1381-1387.
-
(1994)
J Pharmacol Exp Ther
, vol.268
, pp. 1381-1387
-
-
Smith, P.B.1
Welch, S.P.2
Martin, B.R.3
-
31
-
-
44249114538
-
Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products
-
Zacny JP, Gutierrez S. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products. Pain Med. 2008;9:433-443.
-
(2008)
Pain Med
, vol.9
, pp. 433-443
-
-
Zacny, J.P.1
Gutierrez, S.2
|